Thermo Fisher Scientific Influenza A HA Recombinant Rabbit Monoclonal Antibody (133)

Applications

Western Blot (WB)

• Tested Dilution: 1:500–1:1,000

ELISA

• Tested Dilution: 1:1,000–1:2,000

Product Specifications

Product Specific Information

This product is preservative-free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%–0.1%).

Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems developed by cloning specific antibody DNA sequences from immunoreactive rabbits. Individual clones are screened to select the best candidates for production.

Advantages of recombinant rabbit monoclonal antibodies:

• Better specificity and sensitivity
• Lot-to-lot consistency
• Animal origin-free formulations
• Broader immunoreactivity to diverse targets due to larger rabbit immune repertoire

This antibody has specificity for:

• H1N1 (A/California/04/2009) HA
• H1N1 (A/California/07/2009) HA

Target Information

Infectious diseases are a leading cause of death worldwide. AIDS, tuberculosis (TB), malaria, diarrhoeal and respiratory infections account for most deaths caused by infectious disease. As many infectious diseases are controlled, new ones emerge and old diseases become resistant to current drugs. Many infectious diseases have been associated with an increased risk of carcinoma.

Influenza continues to attract researchers as new strains appear due to the ability of the influenza gene to mix with different forms of the virus. Recently, research on SARS and West Nile virus has risen due to the increased number of infections. These antibodies assist in research by detecting infectious disease agents.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.